Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California, San Francisco, California.
Division of Gynecology, Department of Surgery, Boston Children's Hospital, Boston, Massachusetts; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
J Pediatr Adolesc Gynecol. 2024 Dec;37(6):586-594. doi: 10.1016/j.jpag.2024.07.013. Epub 2024 Aug 5.
To assess willingness to provide medication abortion among North American Society for Pediatric and Adolescent Gynecology (NASPAG) clinicians caring for adolescents and young adults (AYA) following Dobbs v. Jackson Women's Health Organization.
Cross-sectional online survey.
Potential participants received an e-mail invitation via the NASPAG listserv. A 43-item questionnaire queried demographics, practice setting, abortion training and practice, willingness to provide medication abortion, potential or real barriers to providing medication abortion, and sentiments of abortion. Descriptive statistics, χ, and Fisher's exact tests were used.
Of the 70 participants, 51% were willing to provide a medication abortion for an adolescent who requested it in their clinical practice. The most common barriers to providing medication abortion were legislative restrictions (47%) and dispensing pills from clinic (33%). Participants' willingness to provide a medication abortion differed by type of practice (P = .001), availability of mifepristone (P = .006), perception of state's abortion policy (P = .001), concern about legislative restrictions (P = .008), experience providing abortion (P = .04), and receipt of medication abortion training (P = .02). Willingness to provide medication abortion also differed based on various sentiments of abortion measured but not on opinion regarding legality of abortion for adolescents (P = .49).
Perception of state's abortion rights and concern about legislative restrictions influenced NASPAG clinicians' willingness to provide medication abortion for adolescents. Interventions to minimize legislative interference with medical care, increase abortion training, and implement medication abortion in pediatric settings may expand AYA medication abortion access.
评估北美小儿和青少年妇科协会（NASPAG）照顾青少年和年轻人（AYA）的临床医生在多布斯诉杰克逊妇女健康组织案后提供药物流产的意愿。
横断面在线调查。
潜在参与者通过 NASPAG 邮件列表收到电子邮件邀请。一份 43 项的问卷询问了人口统计学、实践环境、堕胎培训和实践、提供药物流产的意愿、提供药物流产的潜在或实际障碍以及对堕胎的看法。使用描述性统计、χ 和 Fisher 精确检验。
在 70 名参与者中，51%的人愿意在临床实践中为要求堕胎的青少年提供药物流产。提供药物流产的最常见障碍是立法限制（47%）和从诊所分发药丸（33%）。参与者提供药物流产的意愿因实践类型（P =.001）、米非司酮的可用性（P =.006）、对州堕胎政策的看法（P =.001）、对立法限制的担忧（P =.008）、提供堕胎的经验（P =.04）和接受药物流产培训（P =.02）而有所不同。提供药物流产的意愿也因所测量的各种堕胎态度而有所不同，但与青少年堕胎合法性的意见无关（P =.49）。
对州堕胎权利的看法和对立法限制的担忧影响了 NASPAG 临床医生为青少年提供药物流产的意愿。干预措施旨在最小化立法对医疗保健的干扰，增加堕胎培训，并在儿科环境中实施药物流产，可能会扩大 AYA 药物流产的机会。
